These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695 [TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Zumberg MS; del Rosario ML; Nejame CF; Pollock BH; Garzarella L; Kao KJ; Lottenberg R; Wingard JR Biol Blood Marrow Transplant; 2002; 8(10):569-76. PubMed ID: 12434952 [TBL] [Abstract][Full Text] [Related]
4. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L. Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944 [TBL] [Abstract][Full Text] [Related]
5. Compliance with prophylactic platelet transfusion trigger in haematological patients. Eikenboom JC; van Wordragen R; Brand A Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128 [TBL] [Abstract][Full Text] [Related]
6. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Gmür J; Burger J; Schanz U; Fehr J; Schaffner A Lancet; 1991 Nov; 338(8777):1223-6. PubMed ID: 1682642 [TBL] [Abstract][Full Text] [Related]
7. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy. Callow CR; Swindell R; Randall W; Chopra R Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764 [TBL] [Abstract][Full Text] [Related]
8. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994 [TBL] [Abstract][Full Text] [Related]
9. An audit of platelet transfusion within the Wellington Cancer Centre. Buhrkuhl DC; Karlsson MK; Carter JM Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321 [TBL] [Abstract][Full Text] [Related]
10. Platelet utilization and the transfusion trigger: a prospective analysis. Greeno E; McCullough J; Weisdorf D Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764 [TBL] [Abstract][Full Text] [Related]
11. New strategies for the optimal use of platelet transfusions. Blajchman MA; Slichter SJ; Heddle NM; Murphy MF Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082 [TBL] [Abstract][Full Text] [Related]
13. Lowering platelet-count threshold for transfusion in preterm neonates decreases the number of transfusions without increasing severe hemorrhage events. Billion E; Ghattas S; Jarreau PH; Irmesi R; Ndoudi Likoho B; Patkai J; Zana-Taieb E; Torchin H Eur J Pediatr; 2024 Oct; 183(10):4417-4424. PubMed ID: 39120698 [TBL] [Abstract][Full Text] [Related]
14. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Gil-Fernández JJ; Alegre A; Fernández-Villalta MJ; Pinilla I; Gómez García V; Martinez C; Tomás JF; Arranz R; Figuera A; Cámara R; Fernández-Rañada JM Bone Marrow Transplant; 1996 Nov; 18(5):931-5. PubMed ID: 8932847 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Diedrich B; Remberger M; Shanwell A; Svahn BM; Ringdén O Transfusion; 2005 Jul; 45(7):1064-72. PubMed ID: 15987349 [TBL] [Abstract][Full Text] [Related]
16. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia. Vinholt PJ; Alnor A; Nybo M; Hvas AM Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360 [TBL] [Abstract][Full Text] [Related]
17. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa. Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Kiwanuka N; Wald A PLoS One; 2019; 14(2):e0211648. PubMed ID: 30726290 [TBL] [Abstract][Full Text] [Related]
18. The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry. Kander T; Tanaka KA; Norström E; Persson J; Schött U Anesth Analg; 2014 Oct; 119(4):882-890. PubMed ID: 24854870 [TBL] [Abstract][Full Text] [Related]
19. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy. Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706 [TBL] [Abstract][Full Text] [Related]
20. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]